2 weeks Ago
Novartis India Q2 Results Live : Novartis India declared their Q2 results on 25 October 2024, reporting a topline increase of 10.59% year-over-year. However, the company faced challenges as profit decreased by 13.
81% in the same period. In comparison to the previous quarter, Novartis experienced a decline in revenue by 5.62% and a significant drop in profit by 20.
71%. This indicates potential headwinds the company may need to address moving forward. Notably, the Selling, General & Administrative (SG&A) expenses saw a positive trend, declining by 5.
97% quarter-over-quarter and by 3.17% year-over-year. This reduction could be a strategic move to enhance profitability amid rising costs.
The operating income reported a decrease of 25.79% from the previous quarter, although it did show an increase of 6.89% year-over-year.
This mixed performance highlights the ongoing volatility in operational efficiency. Earnings Per Share (EPS) for Q2 stood at ₹ 8.27, reflecting a decrease of 13.
76% year-over-year, which may concern investors looking for consistent growth. In terms of stock performance, Novartis India has delivered a -4.82% return over the last week, a modest 1.
07% return over the past six months, and an impressive 36.7% year-to-date return, suggesting a mixed sentiment among investors. As of now, Novartis India holds a market capitalization of ₹ 2609.
94 crore, with a 52-week high of ₹ 1248 and a low of ₹ 599.95, indicating significant fluctuations in its stock price over the year. Novartis India Financials.
